Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approves a supplemental application for COMPRO (prochlorperazine) by Padagis US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COMPRO (Prochlorperazine)

Snippet

SUPPL AP for COMPRO (PROCHLORPERAZINE)